<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">phkinetica</journal-id><journal-title-group><journal-title xml:lang="ru">Фармакокинетика и Фармакодинамика</journal-title><trans-title-group xml:lang="en"><trans-title>Pharmacokinetics and Pharmacodynamics</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2587-7836</issn><issn pub-type="epub">2686-8830</issn><publisher><publisher-name>ООО «Издательство ОКИ»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24411/2587-7836-2018-10015.</article-id><article-id custom-type="elpub" pub-id-type="custom">phkinetica-61</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МЕТОДЫ ФАРМАКОДИНАМИЧЕСКОГО ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PHARMACODYNAMIC RESEARCH METHODS</subject></subj-group></article-categories><title-group><article-title>К возможности применения эхокардиографии у мелких лабораторных животных для проведения острых фармакологических тестов</article-title><trans-title-group xml:lang="en"><trans-title>The possibility of using echocardiography in small laboratory animals for acute pharmacological tests</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ионова</surname><given-names>Екатерина Олеговна</given-names></name><name name-style="western" xml:lang="en"><surname>Ionova</surname><given-names>E. O.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Цорин</surname><given-names>Иосиф Борисович</given-names></name><name name-style="western" xml:lang="en"><surname>Tsorin</surname><given-names>I. B.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Барчуков</surname><given-names>Владимир Валерьевич</given-names></name><name name-style="western" xml:lang="en"><surname>Barchukov</surname><given-names>V. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Столярук</surname><given-names>Валерий Николаевич</given-names></name><name name-style="western" xml:lang="en"><surname>Stolyaruk</surname><given-names>V. N.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Крыжановский</surname><given-names>Сергей Александрович</given-names></name><name name-style="western" xml:lang="en"><surname>Kryzhanovskii</surname><given-names>S. A.</given-names></name></name-alternatives><email xlink:type="simple">SAK-538@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «НИИ фармакологии имени В.В. Закусова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>FSBI «Zakusov Institute of Pharmacology»</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБНУ «Научно-исследовательский институт фармакологии имени В.В. Закусова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>FSBI «Zakusov Institute of Pharmacology»</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>06</day><month>03</month><year>2018</year></pub-date><volume>0</volume><issue>2</issue><fpage>59</fpage><lpage>64</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ионова Е.О., Цорин И.Б., Барчуков В.В., Столярук В.Н., Крыжановский С.А., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Ионова Е.О., Цорин И.Б., Барчуков В.В., Столярук В.Н., Крыжановский С.А.</copyright-holder><copyright-holder xml:lang="en">Ionova E.O., Tsorin I.B., Barchukov V.V., Stolyaruk V.N., Kryzhanovskii S.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pharmacokinetica.ru/jour/article/view/61">https://www.pharmacokinetica.ru/jour/article/view/61</self-uri><abstract><p>Цель настоящего исследования - изучение адекватности метода эхокардиографии на мелких лабораторных животных при проведении острых фармакологических тестов. В опытах на белых беспородных крысах-самцах показано, что неселективный агонист ß-адренорецепторов изопротеренол (20 мкг/кг, в/в) уменьшает конечно-систолический и конечно-диастолический размеры и объёмы левого желудочка сердца, измеренные с помощью эхокардиографии, и увеличивает фракции укорочения и выброса, т. е. обладает положительным инотропным эффектом. Кардиоселективный ßl-адреноблокатор метопролол (1 мг/кг, в/в), напротив, увеличивает размеры левого желудочка и уменьшает фракции укорочения и выброса, т. е. обладает отрицательным инотропным эффектом. Таким образом, метод эхокардиографии на мелких лабораторных животных может быть использован для проведения острых фармакологических тестов.</p></abstract><trans-abstract xml:lang="en"><p>Resume. The purpose of this investigation is to study the adequacy of the echocardiography method in small laboratory animals for performing acute pharmacological tests. In experiments on white mongrel male rats, a nonselective ß-adrenoreceptor agonist isoproterenol (20 μg /kg, i.v.) reduces the end-systolic and end-diastolic dimensions and volumes of the heart left ventricle, measured by echocardiography, and increases the shortening and ejection fractions, i.e. has a positive inotropic effect. Cardioselective ß1-adrenoblocker metoprolol (1 mg / kg, i.v.), on the contrary, increases the left ventricle sizes and reduces the shortening and ejection fractions, i.e. has a negative inotropic effect. Thus, the method of echocardiography in small laboratory animals can be used to conduct acute pharmacological tests.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>эхокардиография</kwd><kwd>крысы</kwd><kwd>острые фармакологические тесты</kwd><kwd>изопротеренол</kwd><kwd>метопролол</kwd><kwd>echocardiography</kwd><kwd>rats</kwd><kwd>acute pharmacological tests</kwd><kwd>isoproterenol</kwd><kwd>metoprolol</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Boudia D., Domergue V., Mateo P., et al. Beneficial effects of exercise training in heart failure are lost in male diabetic rats. J. Appl Physiol. (1985). 2017 Dec 1;123(6):1579- 1591. DOI: 10.1152/japplphysiol.00117.2017</mixed-citation><mixed-citation xml:lang="en">Boudia D., Domergue V., Mateo P., et al. Beneficial effects of exercise training in heart failure are lost in male diabetic rats. J. Appl Physiol. (1985). 2017 Dec 1;123(6):1579- 1591. DOI: 10.1152/japplphysiol.00117.2017</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Squair JW, Liu J., Tetzlaff W., et al. Spinal cord injury-induced cardiomyocyte atrophy and impaired cardiac function are severity dependent. Exp Physiol. 2018 Feb 1;103(2):179- 189. DOI: 10.1113/EP086549</mixed-citation><mixed-citation xml:lang="en">Squair JW, Liu J., Tetzlaff W., et al. Spinal cord injury-induced cardiomyocyte atrophy and impaired cardiac function are severity dependent. Exp Physiol. 2018 Feb 1;103(2):179- 189. DOI: 10.1113/EP086549</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Wu LH, Zhang Q., Zhang S., et al. Effects of gene knockdown of CNP on ventricular remodeling after myocardial ischemia-reperfusion injury through NPRB/Cgmp signaling pathway in rats. J. Cell Biochem. 2018 Feb;119(2):1804- 1818. DOI: 10.1002/jcb.26341</mixed-citation><mixed-citation xml:lang="en">Wu LH, Zhang Q., Zhang S., et al. Effects of gene knockdown of CNP on ventricular remodeling after myocardial ischemia-reperfusion injury through NPRB/Cgmp signaling pathway in rats. J. Cell Biochem. 2018 Feb;119(2):1804- 1818. DOI: 10.1002/jcb.26341</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Wang B., Ma X., Zhao L., et al. Injection of basic fibroblast growth factor together with adipose-derived stem cell transplantation: improved cardiac remodeling and function in myocardial infarction. Clin Exp Med. 2016 Nov;16(4):539- 550. DOI: 10.1007/s10238-015-0383-0</mixed-citation><mixed-citation xml:lang="en">Wang B., Ma X., Zhao L., et al. Injection of basic fibroblast growth factor together with adipose-derived stem cell transplantation: improved cardiac remodeling and function in myocardial infarction. Clin Exp Med. 2016 Nov;16(4):539- 550. DOI: 10.1007/s10238-015-0383-0</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Yu B., Wang W. Cardioprotective effects of morroniside in rats following acute myocardial infarction. Inflammation. 2018 Mar;41(2):432-436. DOI: 10.1007/s10753-017-0699-x</mixed-citation><mixed-citation xml:lang="en">Yu B., Wang W. Cardioprotective effects of morroniside in rats following acute myocardial infarction. Inflammation. 2018 Mar;41(2):432-436. DOI: 10.1007/s10753-017-0699-x</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Pessoa FG, Mady C., Fonseca KCB, et al. Erythropoietin reduces collagen deposition after myocardial infarction but does not improve cardiac function. Can J. Physiol Pharmacol. 2018 Jun;96(6):541- 549. DOI: 10.1139/cjpp-2017-0169</mixed-citation><mixed-citation xml:lang="en">Pessoa FG, Mady C., Fonseca KCB, et al. Erythropoietin reduces collagen deposition after myocardial infarction but does not improve cardiac function. Can J. Physiol Pharmacol. 2018 Jun;96(6):541- 549. DOI: 10.1139/cjpp-2017-0169</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Shu L., Zhang W., Huang C., et al. Troxerutin protects against myocardial ischemia/reperfusion injury via pi3k/akt pathway in rats. Cell Physiol Biochem. 2017;44(5):1939- 1948. DOI: 10.1159/000485884</mixed-citation><mixed-citation xml:lang="en">Shu L., Zhang W., Huang C., et al. Troxerutin protects against myocardial ischemia/reperfusion injury via pi3k/akt pathway in rats. Cell Physiol Biochem. 2017;44(5):1939- 1948. DOI: 10.1159/000485884</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Rostamzadeh F., Najafipour H., Yeganeh-Hajahmadi M., Joukar S. Opioid receptors mediate inotropic and depressor effects of apelin in rats with 2K1C-induced chronic renovascular hypertension. Clin Exp Pharmacol Physiol. 2018 Feb;45(2):187- 197. DOI: 10.1111/1440-1681.12860</mixed-citation><mixed-citation xml:lang="en">Rostamzadeh F., Najafipour H., Yeganeh-Hajahmadi M., Joukar S. Opioid receptors mediate inotropic and depressor effects of apelin in rats with 2K1C-induced chronic renovascular hypertension. Clin Exp Pharmacol Physiol. 2018 Feb;45(2):187- 197. DOI: 10.1111/1440-1681.12860</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Tsorin IB, Palka IP, Chichkanov GG. Specific features of the effect of selective anxiolitic afobazole on cardiovascular system. Exp. Clin. Pharmacol. 2009;72(5):41- 45.</mixed-citation><mixed-citation xml:lang="en">Tsorin IB, Palka IP, Chichkanov GG. Specific features of the effect of selective anxiolitic afobazole on cardiovascular system. Exp. Clin. Pharmacol. 2009;72(5):41- 45.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Lang RM, Bierig M., Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J. Am Soc Echocardiogr. 2005; 18( 12): 1440- 1463. DOI: 10.1016/j.echo.2005.10.005</mixed-citation><mixed-citation xml:lang="en">Lang RM, Bierig M., Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J. Am Soc Echocardiogr. 2005; 18( 12): 1440- 1463. DOI: 10.1016/j.echo.2005.10.005</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Fowler NO, Holmes JC. Hemodynamic effects of isoproterenol and norepinephrine in acute cardiac tamponade. J. Clin Invest. 1969;48(3): 502- 507. DOI: 10.1172/JCI106007</mixed-citation><mixed-citation xml:lang="en">Fowler NO, Holmes JC. Hemodynamic effects of isoproterenol and norepinephrine in acute cardiac tamponade. J. Clin Invest. 1969;48(3): 502- 507. DOI: 10.1172/JCI106007</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Fehske W., Grube E., Steinborn W., et al. Cardiac effects of isoproterenol in the complex echocardiographic evaluation. Z. Kardiol. 1980;69(2):81-91.</mixed-citation><mixed-citation xml:lang="en">Fehske W., Grube E., Steinborn W., et al. Cardiac effects of isoproterenol in the complex echocardiographic evaluation. Z. Kardiol. 1980;69(2):81-91.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Nigri A., Mangieri E., Martuscelli E., Reale A. Acute hemodynamic effects of acebutolol and propranolol. Clin Ther. 1984;6(5):693- 698.</mixed-citation><mixed-citation xml:lang="en">Nigri A., Mangieri E., Martuscelli E., Reale A. Acute hemodynamic effects of acebutolol and propranolol. Clin Ther. 1984;6(5):693- 698.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kalischer AL, Johnson LL, Johnson YE, et al. Effects of propranolol and timolol on left ventricular volumes during exercise in patients with coronary artery disease. J. Am Coll Cardiol. 1984;3(1):210-218.</mixed-citation><mixed-citation xml:lang="en">Kalischer AL, Johnson LL, Johnson YE, et al. Effects of propranolol and timolol on left ventricular volumes during exercise in patients with coronary artery disease. J. Am Coll Cardiol. 1984;3(1):210-218.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
